Get started
Author

Elizabeth C. Howell

Observed names: E. Howell, Elizabeth Howell
ORCID: 0000-0001-6957-8714
Observed ORCID: 0000-0001-6957-8714
OpenAlex ID: A5026376368
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al. · Clinical Cancer Research · 336
3′-Deoxy-3′-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer
2015 · Amarnath Challapalli, Tara Barwick, et al. · European Journal of Nuclear Medicine and Molecular Imaging · 29
Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population
2018 · Mavin Macauley, Mohamed Shawgi, et al. · Nuclear Medicine Communications · 26
Evaluating the image quality of combined positron emission tomography-magnetic resonance images acquired in the pelvic radiotherapy position
2020 · Jonathan J Wyatt, Elizabeth Howell, et al. · Physics in Medicine and Biology · 7
PDF
Assessing possible use of CZT technology for application to brain SPECT
2011 · Kjell Erlandsson, Elizabeth Howell, et al. · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · 2
Data from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al. · 1
Qualification of the Seven Dementias Platform UK PET-MR Scanners for Multicentre Trials
2019 · Georgios Krokos, Jane MacKewn, et al. · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · 1
Supplementary Data DS1 from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2025 · Sarah Halford, Gareth J. Veal, et al.
The Use of Positron-Emission Tomography–Magnetic Resonance Imaging to Improve the Local Staging of Disease in Myxofibrosarcoma: A Feasibility Study
2025 · Corey D. Chan, Marcus J. Brookes, et al. · Diagnostics
PDF
Data from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al.
Supplementary Data DS1 from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al.
Supplementary Data DS1 from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al.
Data from A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced Cancer
2023 · Sarah Halford, Gareth J. Veal, et al.
OC-0423 Developing quality assurance tests for simultaneous PET-MR imaging for radiotherapy planning
2021 · J. Wyatt, E. Howell, et al. · Radiotherapy and Oncology
Detection of Bladder Tumours using 18F-fluorothymidine PET-CT
2018 · R.A. Pearson, J.A. Frew, et al. · Clinical Oncology
Evaluation of normal reference range for thyroid uptake of technetium-99 m in a single centre UK population
2017 · Mavin Macauley, Mohamed Shagwi, et al. · Endocrine Abstracts
3 '-Deoxy-3 '-18F-fluorothymidine positron emission tomography as an early predictor of disease progression in patients with advanced and metastatic pancreatic cancer
2015 · Amarnath Challapalli, Tara Barwick, et al. · Newcastle University ePrints (Newcastle Univesity)
An Analytic Computer Simulator for Modular, Pixelated Semi-conductor based SPECT Imaging Systems
2011 · Elizabeth Howell, Kjell Erlandsson, et al. · UCL Discovery (University College London)
Works count: 18
Citation count: 402
H-index: 4
I10-index: 3
Year
Topic
Type